Speech Therapy
Treatment for Orofacial clefts
Typical Dosage: 1-2 sessions per week, 30-60 minutes each
Effectiveness
80%
Safety Score
95%
Clinical Trials
1,500
Participants
150K
Comparative Safety Scale(Higher is safer)
Cyanideβ οΈ
Methπ
Cigarettesπ¬
Chemoβ’οΈ
AlcoholπΊ
Morphineπ
Antibioticsπ
Tylenolπ
Exerciseπ
Waterπ§
95
DangerousModerateSafe
Treatment Details
Dosage Range
1-2 sessions per week, 30-60 minutes each
Time to Effect
Gradual over months to years
Treatment Duration
Variable, 6 months to several years (1-2 sessions/week)
Evidence Quality
HIGHConfidence Score
90%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$0
Monitoring:$7,500
Side Effect Mgmt:$0
Total Annual:$7,500
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
GOODICER
$97,500/QALY
QALYs Gained
1.8
Outcome-Based Costs
Cost per Responder
$8,824
Cost per Remission
$12,500
Speech Therapy Outcomes
for Orofacial clefts
Efficacy Outcomes
Overall Effectiveness
+80%
Response Rate
+85%
Remission Rate
+60%
Common Side Effects
Time commitment
+100%
Patient/family frustration
+30%
Limited progress (severe cases)
+10%
WARNING: LIMITED TRIALS AVAILABLE
You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!
Active Clinical Trials
No active trials currently recruiting for this treatment
No active trials found in ClinicalTrials.gov